E Market Briefing For Tuesday, Dec. 1

Calm prevailed - as is actually a fairly typical post-Thanksgiving trading start, although pundits strained to find more reasons for heightened anxiety.

There are a few, but generally not departing from known issues or exogenous events, that could inhibit a smooth market over the near-term. Those range of course, from a 'somewhat' overbought technical picture (distorted by big-caps versus the broad list which is in no way so extended as pricey FANG+ types), to the domestic political theatrics (valid or not) that continue to trigger debates on how next year will really go.

And there are exogenous risks, like with Iran, of course the tragic pandemic and how that will impact both the health and financial well-being of Americans now that there is optimism (somewhat misplaced or unknown) about vaccine solutions, which do not have the confidence of sufficient numbers of people. I am among skeptics, at least with regard to the first generation vaccines, but if my medical advice is to take it, I will seriously consider it (preferring antibody therapeutics, but we're not at that point yet, though both are needed).

1 2 3 4
View single page >> |
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.
William K. 1 month ago Member's comment

Certainly this plague is a huge disruption of almost everything in the world. It does give the appearance of w well designed weapon, and with that thought, who is, or was, the intended target? It seems more like the hand-grenade with the hundred yard kill radius.

And the big vaccine / antibody concern is that no matter what, any cure will take a long time to reach everybody. The production and inoculation process is not fast, and certainly there will be protesters slowing things as they can. Some companies will make fortunes, and others will not.